Skip to content

TB Alternative Assets Ltd.: MRNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TB Alternative Assets Ltd. on MRNA, newest first. How the timeline and the estimate are built.

TB Alternative Assets Ltd. held 8,700 MRNA shares at 2026-06-30 per its 13F-HR filed 2026-07-17.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 8,700 shares
    Change vs previous 13F +8,700 shares

    0.1% of the 13F portfolio, value $609,261.

    13F-HR 0001193125-26-306709 filed by TB Alternative Assets Ltd.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -658,881 shares

    13F-HR 0001193125-26-014749 filed by TB Alternative Assets Ltd.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-09-30
    13F 658,881 shares
    Change vs previous 13F -602,072 shares

    2.55% of the 13F portfolio, value $17,018,896.

    13F-HR 0001193125-25-241924 filed by TB Alternative Assets Ltd.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 1,260,953 shares
    Change vs previous 13F +608,580 shares

    6.44% of the 13F portfolio, value $34,789,693.

    13F-HR 0000950123-25-006409 filed by TB Alternative Assets Ltd.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 652,373 shares
    Change vs previous 13F not available

    4.3% of the 13F portfolio, value $18,494,775.

    13F-HR 0000950123-25-003471 filed by TB Alternative Assets Ltd.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).